RSS - Posts
A small clinical trial shows psychotherapy with the psychedelic drug MDMA generates brain signals that help relieve symptoms in people with post-traumatic stress disorder. . . . → Read More: Psychedelic Drug Shown to Relieve PTSD Brain Signals
|
|||||
      |
Two developers of virtual reality therapy technology for mental health disorders are combining their operations, and raising $13 million in venture funds. . . . → Read More: Mental Health VR Companies Merge, Raise $13M  Comments are closed  Finance, New products  behavioral science, biomedical, clinical trials, engineering, entrepreneurs, equity, investment, life sciences, medical device, merger, psychiatric, software, U.K., university, venture capital 
A clinical trial is underway testing an experimental drug to treat the underlying causes and symptoms of post-traumatic stress disorder or PTSD. . . . → Read More: Trial Underway Testing PTSD Drug Therapy Comments are closed New products biomedical, clinical trials, Europe, FDA, life sciences, pharmaceuticals, psychiatric, university 
Findings from a clinical trial show an experimental drug helps people in therapy for major depression reduce their symptoms compared to a placebo. . . . → Read More: Trial Shows Results for Depression Drug with Therapy One comment - (Comments are closed) New products biomedical, biotechnology, clinical trials, life sciences, pharmaceuticals, psychiatric 
A clinical trial shows a drug derived from the hallucinogenic compound psilocybin reduces symptoms of depression, when part of a therapy program. . . . → Read More: Trial Shows Psilocybin Drug Helps Reduce Depression Comments are closed New products biomedical, clinical trials, life sciences, pharmaceuticals, psychiatric, university 
Neuroscientists and a software company designed a smartphone app to help front-line professionals diagnose and start treatment for patients with depression. . . . → Read More: Clinician Guidance App Designed for Depression One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, engineering, life sciences, mathematics, medical device, physical sciences, psychiatric, software, university 
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M One comment - (Comments are closed) Finance, Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, psychiatric, university, venture capital 
Results from a clinical trial show an electronic device reporting carbon dioxide content in breath helps people with PTSD reduce symptoms of the disorder. . . . → Read More: Digital Biofeedback Device Shown to Reduce PTSD One comment - (Comments are closed) New products behavioral science, biomedical, clinical trials, engineering, life sciences, medical device, psychiatric, software, university
Two developers of treatments and tools for neurological diseases are developing a system for early detection of agitation, a symptom of psychiatric disorders. . . . → Read More: Biotechs Partner on Agitation Detection Technology One comment - (Comments are closed) Intellectual property, Joint ventures/collaborations biomedical, biotechnology, engineering, life sciences, mathematics, medical device, patent, physical sciences, psychiatric, software 
A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round. . . . → Read More: Psychedelic Therapy Company Raises $80M in New Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, clinical trials, entrepreneurs, equity, investment, life sciences, pharmaceuticals, psychiatric, U.K., venture capital |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||